Vertex Pharmaceuticals Incorporated Common Stock [VRTX]
The TickerPaging button is a members-only feature. (Million)
Annual Financial Data
| Date | Revenue | NetIncome | Operating CF | Assets | Equity |
|---|
| 2017/12 | 2,488.65 | 263.48 | 844.94 | 3,546.01 | 2,028.58 |
| 2018/12 | 3,047.6 | 2,096.9 | 1,270.29 | 6,245.9 | 4,435.2 |
| 2019/12 | 4,162.82 | 1,176.81 | 1,569.33 | 8,318.47 | 6,085.24 |
| 2020/12 | 6,205.68 | 2,711.65 | 3,253.51 | 11,751.81 | 8,686.82 |
| 2021/12 | 7,574.4 | 2,342.1 | 2,643.5 | 13,432.5 | 10,100 |
Annual Indicators
| Date | Stock Price | BPS | PBR | EPS（Annual） | PER（Annual） |
|---|
| 2017/12 | 149.86 | 8.01 | 18.71 | 1.04 | 144.10 |
| 2018/12 | 165.71 | 17.38 | 9.53 | 8.09 | 20.48 |
| 2019/12 | 218.95 | 23.50 | 9.32 | 4.51 | 48.55 |
| 2020/12 | 236.34 | 33.42 | 7.07 | 10.29 | 22.97 |
| 2021/12 | 219.60 | 39.69 | 5.53 | 9.01 | 24.37 |
Quarterly PL/CFS/BS
| Date | Revenue | NetIncome | Operating CF | Operating CF Margin | Equity |
|---|
| 2017/12 | 651.63 | 100.68 | 227.51 | 34.9% | 2,028.58 |
| 2018/03 | 640.8 | 210.26 | 252.66 | 39.4% | 2,401.06 |
| 2018/06 | 752.16 | 207.36 | 321.7 | 42.8% | 2,686.23 |
| 2018/09 | 784.53 | 128.75 | 381.35 | 48.6% | 2,906.12 |
| 2018/12 | 870.11 | 1,550.53 | 314.58 | 36.2% | 4,435.2 |
| 2019/03 | 858.43 | 268.63 | 324.78 | 37.8% | 4,723.31 |
| 2019/06 | 941.29 | 267.43 | 463.75 | 49.3% | 5,069.97 |
| 2019/09 | 949.83 | 57.52 | 334.79 | 35.2% | 5,253.39 |
| 2019/12 | 1,413.27 | 583.23 | 446.01 | 31.6% | 6,085.24 |
| 2020/03 | 1,515.11 | 602.75 | 815.7 | 53.8% | 6,461.65 |
| 2020/06 | 1,524.48 | 837.27 | 1,038.53 | 68.1% | 7,519.24 |
| 2020/09 | 1,538.27 | 667.43 | 907.75 | 59.0% | 8,133.47 |
| 2020/12 | 1,627.82 | 604.19 | 491.53 | 30.2% | 8,686.82 |
| 2021/03 | 1,724.31 | 653.14 | 921.05 | 53.4% | 8,980.25 |
| 2021/06 | 1,793.37 | 66.92 | -199.77 | --% | 9,196.4 |
| 2021/09 | 1,984.16 | 851.93 | 927.22 | 46.7% | 9,530.71 |
| 2021/12 | 2,072.56 | 770.11 | 994.99 | 48.0% | 10,100 |
| 2022/03 | 2,097.5 | 762.1 | 956.2 | 45.6% | 10,907 |
| 2022/06 | 2,196.2 | 810.5 | 1,139.8 | 51.9% | 11,933.5 |
| 2022/09 | 2,334.3 | 930.5 | 955.5 | 40.9% | 13,029.6 |
Quarterly Indicators
| Date | Stock Price | BPS | PBR | EPS(Quarterly) | PER(Annual conversion) | Outstanding Stocks |
|---|
| 2017/12 | 149.86 | 8.01 | 18.71 | 0.39 | 96.06 | 253.253 |
| 2018/03 | 162.98 | 9.42 | 17.30 | 0.81 | 50.30 | 254.868 |
| 2018/06 | 169.96 | 10.54 | 16.13 | 0.80 | 53.11 | 254.883 |
| 2018/09 | 192.74 | 11.37 | 16.95 | 0.50 | 96.37 | 255.611 |
| 2018/12 | 165.71 | 17.38 | 9.53 | 5.97 | 6.94 | 255.172 |
| 2019/03 | 183.95 | 18.43 | 9.98 | 1.03 | 44.65 | 256.351 |
| 2019/06 | 183.38 | 19.75 | 9.29 | 1.03 | 44.51 | 256.671 |
| 2019/09 | 169.42 | 20.42 | 8.30 | 0.22 | 192.52 | 257.265 |
| 2019/12 | 218.95 | 23.50 | 9.32 | 2.23 | 24.55 | 258.993 |
| 2020/03 | 237.95 | 24.94 | 9.54 | 2.29 | 25.98 | 259.079 |
| 2020/06 | 290.31 | 28.91 | 10.04 | 3.18 | 22.82 | 260.124 |
| 2020/09 | 272.12 | 31.26 | 8.71 | 2.53 | 26.89 | 260.174 |
| 2020/12 | 236.34 | 33.42 | 7.07 | 2.30 | 25.69 | 259.89 |
| 2021/03 | 214.89 | 34.70 | 6.19 | 2.49 | 21.58 | 258.829 |
| 2021/06 | 201.63 | 35.49 | 5.68 | 0.26 | 193.88 | 259.114 |
| 2021/09 | 181.39 | 37.20 | 4.88 | 3.28 | 13.83 | 256.206 |
| 2021/12 | 219.60 | 39.69 | 5.53 | 2.98 | 18.42 | 254.479 |
| 2022/03 | 260.97 | 42.68 | 6.11 | 2.96 | 22.04 | 255.575 |
| 2022/06 | 281.79 | 46.61 | 6.05 | 3.13 | 22.51 | 256.026 |
| 2022/09 | 289.54 | 50.77 | 5.70 | 3.59 | 20.16 | 256.646 |
About The Unit
- Revenue,NetIncome,Operating CashFlow,Assets,StockHolder's Equity : Million Dollars
- StockPrice,BPS,EPS,DPS : One USD
- Outstanding Stocks : Million Stocks
- PPBR,PER: Integer multiple